Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Impact of 25-hydroxy vitamin D deficiency and its correction on mineral and bone disorder among hemodialysis patients
2008-002387-33Phase 4Completed
- Sponsor
- Erasmus Hospital
- Start
- May 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of AIDWELL-D3 in chronic kidney disease-mineral and bone disorder (CKD-MBD) and Vitamin D deficiency (VDD), sponsored by Erasmus Hospital. Primary endpoint: Primary mineral metabolism control endpoint. Started May 2008; status: completed.
02
Drugs
AIDWELL-D3
03
Conditions
chronic kidney disease-mineral and bone disorder (CKD-MBD)Vitamin D deficiency (VDD)
Beyond the preview
Go deeper on 2008-002387-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-002387-33.